COAGULO MEDICAL TECHNOLOGIES INC — National Science Foundation SBIR Phase I: MD
COAGULO MEDICAL TECHNOLOGIES INC — SBIR Phase I award from National Science Foundation.
- Amount
- $253,210
- Agency
- National Science Foundation
- Program / Phase
- SBIR · Phase I
- Topic
- MD
- NAICS
- —
- Place of performance
- MA
- Period
- 2020-09-01 → 2021-02-28
Description
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is the development of a rapid, point-of-care device that allows for the precision management of blood clotting (coagulation) disorders and therapies.